13F HOLDINGS REPORT
Vivo Capital, LLC
Quarter ended Q3 2023 · Filed August 14, 2023 · Accession 0001213900-23-067000
Total Value
$1.45B
Positions
48
Other Managers
0
Confidential Omitted
No
Holdings (48)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Sinovac Biotech Ltd. | SVA | 5,900,000 | $615.4M | 42.47% |
| 2 | Harmony Biosciences Holdings Inc | HRMY | 2,606,247 | $91.7M | 6.33% |
| 3 | Verona Pharma PLC | 925050106 | 4,249,918 | $89.8M | 6.20% |
| 4 | Avadel Pharmaceuticals PLC | 05337M104 | 3,829,577 | $63.1M | 4.36% |
| 5 | Terns Pharmaceuticals Inc | TERN | 6,657,992 | $58.3M | 4.02% |
| 6 | Geron Corp | GERN | 16,524,634 | $53.0M | 3.66% |
| 7 | Tarsus Pharmaceuticals Inc | TARS | 2,262,200 | $40.9M | 2.82% |
| 8 | Viridian Therapeutics Inc | VRDN | 1,678,207 | $39.9M | 2.76% |
| 9 | VectivBio Holding AG | H9060V101 | 2,333,300 | $39.4M | 2.72% |
| 10 | Chinook Therapeutics Inc | 16961L106 | 934,879 | $35.9M | 2.48% |
| 11 | ALX Oncology Holdings Inc | ALXO | 4,220,048 | $31.7M | 2.19% |
| 12 | Cogent Biosciences Inc | COGT | 2,244,941 | $26.6M | 1.83% |
| 13 | Icosavax, Inc. | 45114M109 | 1,704,568 | $16.9M | 1.17% |
| 14 | Gracell Biotechnologies Inc | 38406L103 | 3,969,427 | $15.1M | 1.04% |
| 15 | Astria Therapeutics Inc | 04635X102 | 1,681,199 | $14.0M | 0.97% |
| 16 | Ventyx Biosciences Inc | 92332V107 | 422,075 | $13.8M | 0.96% |
| 17 | Arcellx Inc. | ACLX | 433,785 | $13.7M | 0.95% |
| 18 | Allakos Inc | 01671P100 | 2,988,000 | $13.0M | 0.90% |
| 19 | Zai Lab Ltd ADR | ZLAB | 445,505 | $12.4M | 0.85% |
| 20 | Olema Pharmaceuticals Inc | OLMA | 1,339,271 | $12.1M | 0.83% |
| 21 | Verastem Inc | VSTM | 1,538,461 | $11.4M | 0.79% |
| 22 | Compass Therapeutics Inc | CMPX | 3,556,023 | $11.3M | 0.78% |
| 23 | Aslan Pharmaceuticals Ltd | 04522R101 | 2,840,908 | $10.4M | 0.72% |
| 24 | Alpine Immune Sciences Inc | 02083G100 | 914,913 | $9.4M | 0.65% |
| 25 | Aclaris Therapeutics, Inc. | ACRS | 898,631 | $9.3M | 0.64% |
| 26 | Amyris, Inc | 03236M200 | 7,750,828 | $8.0M | 0.55% |
| 27 | KalVista Pharmaceuticals Inc. | KALV | 856,008 | $7.7M | 0.53% |
| 28 | Genetron Holdings Ltd | 37186H100 | 8,124,174 | $7.6M | 0.52% |
| 29 | Instil Bio Inc | TIL | 12,486,787 | $6.9M | 0.47% |
| 30 | Delcath Systems, Inc. | DCTH | 1,178,787 | $6.9M | 0.47% |
| 31 | Dyne Therapeutics Inc | DYN | 577,642 | $6.5M | 0.45% |
| 32 | Aadi Bioscience Inc | WHWK | 509,572 | $6.5M | 0.45% |
| 33 | Sera Prognostics Inc | SERA | 1,856,011 | $6.1M | 0.42% |
| 34 | IO Biotech Inc | IOBT | 3,015,545 | $5.9M | 0.41% |
| 35 | DBV Technologies SA | DBVTF | 2,708,875 | $5.1M | 0.36% |
| 36 | Bolt Therapeutics Inc | BOLT | 3,871,291 | $5.0M | 0.34% |
| 37 | Arrowhead Pharmaceuticals Inc | ARWR | 137,411 | $4.9M | 0.34% |
| 38 | Iovance Biotherapeutics Inc | IOVA | 655,057 | $4.6M | 0.32% |
| 39 | Clene Inc | CLNN | 4,520,622 | $3.7M | 0.26% |
| 40 | Impel NeuroPharma Inc | 45258K109 | 2,884,789 | $3.7M | 0.25% |
| 41 | Aligos Therapeutics Inc | ALGS | 3,547,030 | $3.4M | 0.24% |
| 42 | BioAtla Inc | BCAB | 637,181 | $1.9M | 0.13% |
| 43 | Fulcrum Therapeutics Inc | FULC | 550,000 | $1.8M | 0.13% |
| 44 | Immunic Inc | IMUX | 632,184 | $1.6M | 0.11% |
| 45 | Codexis, Inc | CDXS | 388,144 | $1.1M | 0.08% |
| 46 | Rezolute Inc | RZLT | 489,473 | $969,157 | 0.07% |
| 47 | Homology Medicines, Inc. | 438083107 | 370,068 | $327,510 | 0.02% |
| 48 | Precision Biosciences Inc | DTIL | 140,255 | $73,774 | 0.01% |